Bioprosthesis: Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.Heart Valve Prosthesis: A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.Heart Valve Prosthesis Implantation: Surgical insertion of synthetic material to repair injured or diseased heart valves.Aortic Valve: The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.Prosthesis Design: The plan and delineation of prostheses in general or a specific prosthesis.Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).Prosthesis Failure: Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking.Reoperation: A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.Tricuspid Valve Stenosis: The pathologic narrowing of the orifice of the TRICUSPID VALVE. This hinders the emptying of RIGHT ATRIUM leading to elevated right atrial pressure and systemic venous congestion. Tricuspid valve stenosis is almost always due to RHEUMATIC FEVER.Prosthesis Fitting: The fitting and adjusting of artificial parts of the body. (From Stedman's, 26th ed)Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).Anatomic Landmarks: Reference points located by visual inspection, palpation, or computer assistance, that are useful in localizing structures on or within the human body.Mitral Valve: The valve between the left atrium and left ventricle of the heart.Device Removal: Removal of an implanted therapeutic or prosthetic device.Abortion, Septic: Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.Tricuspid Valve: The valve consisting of three cusps situated between the right atrium and right ventricle of the heart.Pericardium: A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.Cardiac Catheterization: Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Tricuspid Valve Insufficiency: Backflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.Calcinosis: Pathologic deposition of calcium salts in tissues.Echocardiography, Transesophageal: Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.Endocarditis, Bacterial: Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.Hemodynamics: The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.Atrial Appendage: Ear-shaped appendage of either atrium of the heart. (Dorland, 28th ed)Thoracic Surgical Procedures: Surgery performed on the thoracic organs, most commonly the lungs and the heart.Thoracic Surgery: A surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular.Cardiac Surgical Procedures: Surgery performed on the heart.Cardiopulmonary Bypass: Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)Sinus Arrest, Cardiac: The omission of atrial activation that is caused by transient cessation of impulse generation at the SINOATRIAL NODE. It is characterized by a prolonged pause without P wave in an ELECTROCARDIOGRAM. Sinus arrest has been associated with sleep apnea (REM SLEEP-RELATED SINUS ARREST).Calcium, Dietary: Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.Heart Valves: Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.Ontario: A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. (From Webster's New Geographical Dictionary, 1988, p892 & Room, Brewer's Dictionary of Names, 1992, p391)LondonPerioperative Care: Interventions to provide care prior to, during, and immediately after surgery.British Columbia: A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. (From Webster's New Geographical Dictionary, 1988, p178 & Room, Brewer's Dictionary of Names, 1992, p81-2)Canada: The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.Academic Medical Centers: Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.Pulmonary Valve: A valve situated at the entrance to the pulmonary trunk from the right ventricle.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Heart, Artificial: A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.von Willebrand Factor: A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.Factor VIII: Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.Angiodysplasia: Acquired degenerative dilation or expansion (ectasia) of normal BLOOD VESSELS, often associated with aging. They are isolated, tortuous, thin-walled vessels and sources of bleeding. They occur most often in mucosal capillaries of the GASTROINTESTINAL TRACT leading to GASTROINTESTINAL HEMORRHAGE and ANEMIA.Blood Transfusion: The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)von Willebrand Disease, Type 2: A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
"A new bioprosthesis for aortic and mitral valve replacement: Preliminary evaluation of the Tascon valve". Texas Heart Institute ... The human heart contains four valves: tricuspid valve, pulmonic valve, mitral valve and aortic valve. Their main purpose is to ... To easily remove the old replaceable bioprostheses, its "stent" can be sectioned to dismount its framework and so facilitate ... bioprostheses or "tissue valves"), the replaceable models of implantable heart valve prostheses are made by two or three ...
Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: Up to 17 year follow-up in ... 1965 Binet and associates in Paris, France, began the use of porcine aortic valves for aortic valve replacement in humans. 1967 ... Sorin Pericarbon Pericardial Valve A =Aortic; M = Mitral; D = Mitral and Aortic; T = Tricuspid; P = Pulmonary; SVD = Structural ... Mitroflow Pericardial Valve A = Aortic; M = Mitral; D = Mitral and Aortic, T = Tricuspid, SVD = Structural Valve Deterioration ...
Lim, W. L.; Chew, Y. T.; Chew, T. C.; Low, H. T. (2001-11-01). "Pulsatile flow studies of a porcine bioprosthetic aortic valve ... In this category we find examples such as animal tissue prostheses (xenogeneic bioprosthesis). Xenogeneic heart valves are of ... see Aortic valve replacement). In vitro calcification models have been used in medical implant development to evaluate the ... "In vitro testing of bioprostheses: influence of mechanical stresses and lipids on calcification". The Annals of Thoracic ...
Scapulae-based aortic valve replacement. Catheter replacement of the aortic valve (called trans-aortic valve replacement or ... surgery is the replacement of one or more of the heart valves with either an artificial heart valve or a bioprosthesis ( ... In those between 50 and 70 years of age bioprosthetic and mechanical aortic valves have similar overall outcomes with respect ... There are four procedures Aortic valve replacement Mitral valve replacement Tricuspid valve replacement Pulmonary valve ...
"Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis ... "Surgical aortic heart valves , Edwards Lifesciences". www.edwards.com. Pridobljeno dne 2019-07-29.. ... "Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants". The Annals of Thoracic Surgery. 99 (4 ...
Cosgrove A M, Lytle B W, Taylor P C, Camacho M T, Stewart R W, et al (1995) "The Carpentier-Edwards pericardial aortic valve; ... Carpentier-Edwards Pericardial Bioprosthesis.' This valve is reported to perform better than its predecessor, the original ... Ionescu M I, Holden M D, Petrila P A "Fascia Lata Heart Valves; with section on Free Fascia Lata Grafts for Aortic Valve ... This was followed by the creation of the Dacron covered titanium frame for mounting the porcine aortic valves to be able to ...
"A new bioprosthesis for aortic and mitral valve replacement: Preliminary evaluation of the Tascon valve". Texas Heart Institute ... The human heart contains four valves: tricuspid valve, pulmonic valve, mitral valve and aortic valve. Their main purpose is to ... To easily remove the old replaceable bioprostheses, its "stent" can be sectioned to dismount its framework and so facilitate ... bioprostheses or "tissue valves"), the replaceable models of implantable heart valve prostheses are made by two or three ...
1962- aortic homografts are introduced 1965- glutaraldehyde-preserved porcine bioprostheses 1969- disc valves ... This valve did not replace the patients diseased aortic valve but instead it was inserted in the descending aorta in an open- ... There are four heart valves: tricuspid, mitral, pulmonic, and aortic. These valves ensure that each muscle contraction produces ... There are four heart valves: tricuspid, mitral, pulmonic, and aortic. These valves ensure that each muscle contraction produces ...
Hemodynamic performance of Mitroflow aortic pericardial bioprosthesis: optimizing management for the small aortic annulus. ... Mitroflow aortic bioprosthesis 5-year follow-up: North American Prospective Multicenter Study. Ann Thorac Surg. 2012;94:1198- ... Early Structural Valve Deterioration of the Mitroflow Aortic Bioprosthesis. Tsuyoshi Kaneko, Igor Gosev, Marzia Leacche, John G ... The Mitroflow aortic prosthesis (Sorin Group Inc) is one of the most frequently used bioprostheses, with ,100 000 implanted ...
Aortic Bioprosthesis. ATS Medical acknowledged the positive clinical results of aortic root dimensions study presented by noted ... Louis, Missouri, and principal in the development of the ATS 3f(R) Aortic Bioprosthesis offered his comments on Dr. Jins ... Preserving the aortic root in its natural form is but one more indication that the ATS 3f aortic valve prosthesis is ... The ATS 3f valve with no direct sutures in the aortic sinus fully preserved the native aortic root geometry without ...
One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. The European ... Methods and Results-The Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry was designed to assess initial ... One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry ... One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry ...
Percutaneous aortic valve replacement is an emerging alternative for high surgical risk patients with native aortic valve ... Percutaneous aortic valve replacement is an emerging alternative for high surgical risk patients with native aortic valve ... 8087265 - Doppler derived aortic valve resistance in aortic stenosis: its hemodynamic validation.. 1841025 - Development and ... valve-in-valve procedure with a CoreValve prosthesis for the treatment of a severely stenotic degenerated aortic bioprosthesis. ...
Percutaneous Aortic CoreValve Prosthesis in a Degenerated Bioprosthesis Prótesis aórtica percutánea CoreValve sobre prótesis ... We report the first case of successful treatment of severe stenosis of a degenerated aortic bioprosthesis using the ... Carpentier-Edwards bioprosthesis) in 2005 to treat aortic stenosis, presented with symptoms of heart failure. Transthoracic and ... A 29-mm CoreValve aortic prosthesis was implanted without complications through a femoral artery approach. The gradient peak ...
The ATS 3f Aortic Bioprosthesis is the Companys first entry into ... The ATS 3f Aortic Bioprosthesis is the only tissue valve ... that pre...,ATS,Medical,Announces,First,Commercial,Implants,of,the,ATS,3f,Aortic,Bioprosthesis,in,the,United,States,medicine, ... The ATS 3f Aortic Bioprosthesis is the Companys first entry into ... The ATS 3f Aortic Bioprosthesis is the only tissue valve ... By maintaining this continuity, the ATS 3f Aortic Bioprosthesis preserves the aortic sinuses and restores native valve stress ...
A Case of Acute Aortic Regurgitation due to Leaflet Dehiscence of a Carpentier-Edwards Pericardial Bioprosthesis 16 Years after ... A 39-year-old woman, who had undergone aortic valve replacement with a Carpentier-Edwards pericardial bioprosthesis 16 years ... Aortic valve replacement was performed with a mechanical heart valve but it was impossible to wean from ECC, and therefore we ... One of the leaflets of the CEP was entirely collapsed and dislocated to the LV side, which caused acute aortic regurgitation. ...
aortic regurgitation, aortic stenosis, bovine pericardial bioprosthesis, surgical aortic valve replacement Persistent URL. dx. ... One-year outcomes associated with a novel stented bovine pericardial aortic bioprosthesis. Publication. Publication. The ... Methods: This trial enrolled patients with symptomatic moderate or severe aortic stenosis or chronic, severe aortic ... One-year outcomes associated with a novel stented bovine pericardial aortic bioprosthesis. The Journal of Thoracic and ...
Stentless porcine bioprostheses in the treatment of aortic valve infective endocarditis ... Stentless aortic bioprostheses: their role in the treatment of aortic endocarditis should not be underestimated. European ... Stentless porcine bioprostheses in the treatment of aortic valve infective endocarditis. Stentless porcine bioprostheses in the ... Placement of aortic valve bioprostheses in sheep via a left thoracotomy. Implantation of stentless porcine heterografts. Asaio ...
Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses ... Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses ... Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses ... registry between 2007 and 2016 from a total of 1,598 aortic ViV procedures (291 stentless, 1,307 stented bioprostheses). ...
Aortic valve replacement Intervention. Prima Plus (Edwards Lifesciences) stentless bioprosthesis or the Carpentier-Edwards ... Prospective randomised trial of stented versus stentless bioprosthesis for aortic valve replacement (AVR). ... 2. AVR performed primarily for aortic valve regurgitation. 3. Active aortic valve infection. 4. Active malignant disease. 5. ... 1. Patients who require elective AVR with a tissue valve for symptomatic aortic valve stenosis (peak valve gradient equal to or ...
Surgically implanted aortic valve bioprostheses deform after implantation: insights from computed tomography. Publication. ... Key Points: • Deformation of surgically implanted aortic valve bioprostheses (bio-sAVRs) can be adequately assessed using MDCT ... Surgically implanted aortic valve bioprostheses deform after implantation: insights from computed tomography. European ... Bioprosthesis, Heart valve prosthesis, Multidetector-row computed tomography Persistent URL. dx.doi.org/10.1007/s00330-019- ...
Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: mid-term clinical results. ... is excellent and consider the Carpentier-Edwards pericardial valve as the stented bioprosthesis of choice both in the aortic ... and both aortic and mitral (n = 23) positions at the Gasthuisberg University Hospital in Leuven, Belgium. Patients undergoing ... for aortic valve replacement and 7.3% +/- 4.06% (n = 41) for mitral valve replacement. Hospital mortality was 14.1% +/- 3.27% ...
... lead to the most serious conditions related to aortic wall with life-threatening complications. The most common modality of ... Fabrication of aortic bioprosthesis by decellularization, fibrin glue coating and re-endothelization: a cell scaffold approach ... Aortic dysfunctions (aneurysm, aortitis) lead to the most serious conditions related to aortic wall with life-threatening ... Another devastating aortic disease is an aortitis which encompasses inflammatory reactions in the aortic vessel wall associated ...
It may be an option for patients with a failed aortic bioprosthesis, especially when the risk of a surgical redo is deemed ... Background Transcatheter aortic valve implantation with the CRS is an effective option in high-risk patients with severe aortic ... Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses ... Transcatheter Valve-in-Valve Implantation Using CoreValve Revalving System for Failed Surgical Aortic Bioprostheses ...
Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings ... Simultaneous transcatheter aortic and mitral valve-in-valve implantation in a patient with degenerated bioprostheses and high ... Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral ... Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. ...
TCT-357 Transcatheter Aortic Valve Replacement with a 34-mm Repositionable Self-Expanding Bioprosthesis ... TCT-357 Transcatheter Aortic Valve Replacement with a 34-mm Repositionable Self-Expanding Bioprosthesis ... TCT-357 Transcatheter Aortic Valve Replacement with a 34-mm Repositionable Self-Expanding Bioprosthesis ... AS, aortic stenosis; BAV, balloon aortic valvuloplasty; MSCT, multi-slice computed tomography; NYHA, New York Heart Association ...
... after aortic valve implantation in the 3 aortic bioprosthesis groups: percutaneous aortic valve implantation (PAVI) (circles); ... Aortic Regurgitation Data at Discharge and at Follow-Up Grouped According to Type of Aortic Bioprosthesis ... 1998) Hemodynamic features of the Freestyle aortic bioprosthesis compared with stented bioprosthesis. Ann Thorac Surg 66(Suppl ... in the 3 aortic bioprosthesis groups at hospital discharge and at follow-up according to the aortic annulus size: percutaneous ...
Holmes, D., & Mack, M. J. (2017). Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis. Circulation, 135(18), ... Aortic Valve Bioprostheses : Leaflet Immobility and Valve Thrombosis. / Holmes, David; Mack, Michael J. ... Holmes, D & Mack, MJ 2017, Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis, Circulation, vol. 135, no. 18 ... Holmes, David ; Mack, Michael J. / Aortic Valve Bioprostheses : Leaflet Immobility and Valve Thrombosis. In: Circulation. 2017 ...
... pulmonary valve bioprosthesis / tricuspid / aortic / mitral . Contact a supplier or the parent company directly to get a quote ... The Porcine Organic Valvular Bioprosthesis is indicated for mitral, aortic, tricuspid or pulmonary valve replacements. ... PORCINE ORGANIC VALVULAR BIOPROSTHESIS. DESCRIPTION. The Bovine Pericardium Organic Valvular Bioprosthesis consists of bovine ... The bioprosthesis is made on a support of polyacetal coated with bovine pericardium on which the cusps are mounted. A special ...
The aortic Carpentier-Edwards pericardial bioprosthesis offers good long-term clinical outcomes with a low rate of structural ... The aortic Carpentier-Edwards pericardial bioprosthesis offers good long-term clinical outcomes with a low rate of structural ... The aortic Carpentier-Edwards pericardial bioprosthesis offers good long-term clinical outcomes with a low rate of structural ... The aortic Carpentier-Edwards pericardial bioprosthesis offers good long-term clinical outcomes with a low rate of structural ...
Complex Valve-in-Valve (VIV) TAVI for Aortic bioprosthesis dysfunction. Case of the month: July 2018 ... Managing degenerative aortic bioprosthesis with Valve -in-Valve implantation in High risk patients. ... This didactic procedure concerns a 81 y.o gentelman, with history of Surgical Aortic valve bioprosthesis replacement with ... This didactic procedure concerns a 81 y.o gentelman, with history of Surgical Aortic valve bioprosthesis replacement with ...
Erdem, Can C. ; Park, Soon J. / A smart method of intraoperative explantation of an aortic bioprosthesis. In: Journal of ... Erdem, C. C., & Park, S. J. (2009). A smart method of intraoperative explantation of an aortic bioprosthesis. Journal of ... A smart method of intraoperative explantation of an aortic bioprosthesis. Journal of Cardiac Surgery. 2009 Sep;24(5):515-517. ... Erdem, CC & Park, SJ 2009, A smart method of intraoperative explantation of an aortic bioprosthesis, Journal of Cardiac ...
  • Nine patients had native valve in endocarditis, the presence of a bicuspid aortic valve in 2, and 1 patient had recurrent prosthetic valve endocarditis (PVE), 7 of whom were in New York Heart Association (NYHA) Functional Class IV. (eurekamag.com)
  • From first aortic root replacement reported by Bentall and De Bono in 1968 to aortic root reimplantation (David procedure) and remodeling (Yacoub operation) with multiple contemporary modifications, aortic root reconstruction now is widely used in treatment of chronic aortic aneurysmal disease and acute aortic dissections alike. (intechopen.com)
  • Phillips SJ, Ciborski M, Freed PS et al (1976) A temporary catheter-tip aortic valve: hemodynamic effects on experimental acute aortic insufficiency. (springer.com)
  • ATS Medical acknowledged the positive clinical results of aortic root dimensions study presented by noted cardiologist Dr. Xu Yu Jin. (emaxhealth.com)
  • With more than six years of clinical experience confirming excellent safety and efficacy, the demonstrated clinical benefit and recent FDA approval of the ATS 3f Aortic Bioprosthesis are creating excitement and product demand among U.S. surgeons. (bio-medicine.org)
  • Uncertainty about the incidence and clinical significance of the findings is the basis of 2 US Food and Drug Administration-approved studies comparing transcatheter and surgical aortic valve replacement with a subset undergoing surveillance 4-dimensional computerized tomographic imaging. (elsevier.com)
  • Clinical research interests include thoracic aortic diseases (aneurysms, dissections). (stanford.edu)
  • Aortic root reconstruction represents one of the most complex areas of cardiac surgery as well as one of the most dynamic-major developments in understanding of the aortic root anatomy and physiology, improvements in imaging and surgical technique allowed for development and acceptance into clinical practice of several novel procedures over last couple of decades. (intechopen.com)
  • Block PC, Palacios IF (1988) Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. (springer.com)
  • The Toronto Root bioprosthesis with BiLinx anticalcification treatment (St. Jude Medical, St. Paul, MN) was introduced into clinical practice in 2001, mainly for patients with aortic valve disease and additional pathology of the aorta. (ovid.com)
  • The Toronto Root bioprosthesis is safe and provides good clinical and hemodynamic function after full root replacement with or without additional aortic surgery. (ovid.com)
  • To assess the clinical implementation and report preliminary results of a novel technique called the Ozaki procedure for stentless aortic valve replacement through reconstruction of the valve leaflets from autologous pericardium. (smw.ch)
  • Partial, preliminary findings of the first randomized, controlled trial comparing PHVR with medical therapy, including balloon aortic valvuloplasty, are expected in September 2010. (annals.org)
  • Safian RD, Berman AD, Diver DJ et al (1988) Balloon aortic valvuloplasty in 170 consecutive patients. (springer.com)
  • Otto CM, Mickel MC, Kennedy JW et al (1994) Three-year outcome after balloon aortic valvuloplasty. (springer.com)
  • Objective: Little is known about the prevalence and degree of deformation of surgically implanted aortic biological valve prostheses (bio-sAVRs). (eur.nl)
  • Molecular and genetic mechanisms of aortic aneurysm/dissection development. (stanford.edu)
  • These 2 bovine pericardial bioprostheses have been widely adopted at most centres and we aimed to compare TF with FS, the most recently available models of their respective counterparts. (deepdyve.com)
  • Early Anticoagulation Regimen Comparison in the Mosaic Aortic Bioprosthesis. (rigshospitalet.dk)
  • James L. Cox, MD, Emeritus Evarts A. Graham Professor of Surgery, Washington University School of Medicine, St. Louis, Missouri, and principal in the development of the ATS 3f(R) Aortic Bioprosthesis offered his comments on Dr. Jin's observations. (emaxhealth.com)
  • ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f(R) Aortic Bioprosthesis were completed by Dr. Allan Stewart, Director, Aortic Surgery Program at Columbia University Medical Center in New York ( http://www.ctsnet.org/home/allanstewart ) on November 17 and 18, 2008. (bio-medicine.org)
  • Erdem, CC & Park, SJ 2009, ' A smart method of intraoperative explantation of an aortic bioprosthesis ', Journal of Cardiac Surgery , vol. 24, no. 5, pp. 515-517. (elsevier.com)
  • Basic principles of aortic root structure and function and critical operative strategies for aortic root surgery are reviewed in this chapter. (intechopen.com)
  • The technique of aortic root surgery has undergone many improvements during the past decades. (intechopen.com)
  • As the first centre for cardiac surgery in Europe, we started performing aortic valve replacement with autologous pericardium in September 2015 after CE certification. (smw.ch)